LLY

1,104.03

+0.68%↑

JNJ

231.1

+1.28%↑

ABBV

229.8

+6.05%↑

UNH

406.18

+1.48%↑

NVS

148.46

+1.12%↑

LLY

1,104.03

+0.68%↑

JNJ

231.1

+1.28%↑

ABBV

229.8

+6.05%↑

UNH

406.18

+1.48%↑

NVS

148.46

+1.12%↑

LLY

1,104.03

+0.68%↑

JNJ

231.1

+1.28%↑

ABBV

229.8

+6.05%↑

UNH

406.18

+1.48%↑

NVS

148.46

+1.12%↑

LLY

1,104.03

+0.68%↑

JNJ

231.1

+1.28%↑

ABBV

229.8

+6.05%↑

UNH

406.18

+1.48%↑

NVS

148.46

+1.12%↑

LLY

1,104.03

+0.68%↑

JNJ

231.1

+1.28%↑

ABBV

229.8

+6.05%↑

UNH

406.18

+1.48%↑

NVS

148.46

+1.12%↑

Search

Bausch Health Cos Inc

Închisă

SectorSănătate

4.65 -2.11

Rezumat

Modificarea prețului

24h

Curent

Minim

4.6

Maxim

4.75

Indicatori cheie

By Trading Economics

Venit

-1.3B

-1.4B

Vânzări

-350M

2.5B

P/E

Medie Sector

13.286

49.712

EPS

0.78

Marjă de profit

-57.492

Angajați

20,300

EBITDA

-1.3B

-648M

Recomandări

By TipRanks

Recomandări

Neutru

Prognoză pe 12 luni

+60.8% upside

Dividende

By Acuity

Următoarele câștiguri

29 iul. 2026

Statistici piață

By TradingEconomics

Capitalizare de piață

-220M

1.9B

Deschiderea anterioară

6.76

Închiderea anterioară

4.65

Bausch Health Cos Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Despre Bausch Health Cos Inc

Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health. The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The Salix segment provides gastroenterology products in the United States. The International segment sells aesthetic medical devices, branded pharmaceuticals, generic pharmaceuticals, and OTC products internationally. The Solta Medical segment engages in the sale of aesthetic medical devices. The Diversified segment offers pharmaceutical products in the areas of neurology and certain other therapeutic classes; generic products; ortho dermatologic; and dentistry products in the United States. The Bausch + Lomb segment offers products in the areas of vision care, surgical, and ophthalmic pharmaceuticals products. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.
help-icon Live chat